Addictions: a major Public Health threat
Huge medical need : not well addressed by present solutions
Addiction is a huge problem we try to solve. The market is more than 3 billion USD and involve more than 35M people.
In a regulatory point of view, the addiction was finally recognized as a real chronic pathology of the central nervous system in August, 2011 by the American Society for Addiction Medicine and validated by NIDA.
Addiction market estimations
- 63 million people are affected by alcohol-dependence in USA and in Europe.
- 3,3 million deaths every year in the world are attributable to the alcohol abuse.
- Healthcare costs: more than 5 % of the world load of the diseases and traumas.
- 3,3 million deaths every year in the world are attributable to the alcohol abuse.
- In France social cost : 120 bio for alcohol and 120 bio for tobacco.
- Today anti addiction drug market 1.5 € bio (+20%/year)?
Deal realized in 2011 in the
field of the addiction
It concerns Biotie and Lundbeck companies for Selincro (Nalmefene) at the end of 2011 in phase 2:
- Upfront : 12 million euros
- Milestones : 84 million euros
- Royalties : not revealed
- Royalties : not revealed
Last realized deal (2013)
It concerns XenoPort companies and Reckitt Benckiser for Arbaclofen in phase 2:
- Upfront : 25 million USD
- Milestones : 70 million USD + 50 million USD
- Royalties : not revealed